1. Discovery and Development of Trifluridine/Tipiracil (Lonsurf ™)
   Norihiko Suzuki et al, 2018, Successful Drug Discovery CrossRef
2. Trifluridine/tipiracil: an emerging strategy for the management of gastrointestinal cancers
   Marc Peeters et al, 2018, Future Oncology CrossRef
3. Further Therapeutic Options in Heavily Pretreated Colorectal Cancer Patients
   Aneta L. Zygulska, 2019, Multidisciplinary Approach for Colorectal Cancer CrossRef
4. Trifluridine / tipiracil (FTd / TPI, TAS-102) in the treatment of patients with metastatic colon cancer: from preclinical experiments to routine clinical practice
   M. Yu. Fedyanin, 2020, Pelvic Surgery and Oncology CrossRef
5. Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study design
   Josep Tabernero et al, 2021, Future Oncology CrossRef
6. Quantitative Analysis of the Concentration of Trifluridine in Tumor Hypoxic Regions Using a Novel Platform Combining Functional Endoscopy and Mass Spectrometry
   Shigehiro Koganemaru et al, 2024, Clinical Pharmacology & Therapeutics CrossRef
7. Recent advance in the development of novel, selective and potent FGFR inhibitors
   Feng-Tao Liu et al, 2020, European Journal of Medicinal Chemistry CrossRef
8. Pyrimidine-based anticancer drugs
   Galal H. Elgemeie et al, 2022, New Strategies Targeting Cancer Metabolism CrossRef
9. Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer
   Kirti K. Iyer et al, 2022, Cancer Treatment Reviews CrossRef
10. Extrapolating heterogeneous time-series gene expression data using Sagittarius
    Addie Woicik et al, 2023, Nature Machine Intelligence CrossRef